Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
EAF1 antisense RNA 1 (EAF1-AS1) is a long non-coding RNA (lncRNA) transcribed from the antisense strand of the EAF1 gene locus. Like other antisense lncRNAs, EAF1-AS1 is presumed to regulate the expression or processing of its sense gene, EAF1, through transcriptional, post-transcriptional, or epigenetic mechanisms. While many antisense lncRNAs have demonstrated roles in the regulation of proliferation, differentiation, and disease, specific functional or mechanistic details for EAF1-AS1 are not available in the current literature from the search results. Diseases associated include retinitis pigmentosa, though no direct mechanistic linkage or therapeutic targeting data is reported. EAF1-AS1 is not presently considered a therapeutic target, receptor, or enzyme.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on EAF1 antisense RNA 1 (EAF1-AS1).